Detail page

Knowledge Web

Person

Giuseppe Mancia

Kardiologe

Name	Giuseppe Mancia
Place	Monza (Wirkungsort) Italien
Gender	männlich
Academic degree	Dr. med.
Profession	Kardiologe (characteristic profession) Rheumatologe
Variant	G. Mancia
Further information	Leiter der Abteilung für Innere Medizin, San Gerardo-Krankenhaus, Monza. Forschungsschwerpunkte: Pathophysiologie, klinische Pharmakologie, Therapie von Bluthochdruck, Herzinsuffizienz
Source	Homepage Radcliffe Cardiology: http://www.touchcardiology.com/authors/giuseppe-mancia (Stand: 20.03.2018)
Record type	Person
GND-Identifier	121717364
Record ID	121717364
Involved in show all Hypertension and Heart Failure : Epidemiology, Mechanisms and Treatment Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control History of lower-limb complications and risk of cancer death in people with type 2 diabetes Renal denervation in high-risk patients with hypertension The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study Associations between body mass index and the risk of renal events in patients with type 2 diabetes Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours Cardiorenal Syndrome : Mechanisms, Risk and Treatment Cardiovascular protection for all individuals at high risk: evidence-based best practice Aggiorn@rsi in Rete Ipertensione arteriosa : attualita dal Web, trial clinici in rete, liste, gruppi e canali di discussione, videoconferenze

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Giuseppe Mancia

Hypertension and Heart Failure : Epidemiology, Mechanisms and Treatment

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range

Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

History of lower-limb complications and risk of cancer death in people with type 2 diabetes

Renal denervation in high-risk patients with hypertension

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

Associations between body mass index and the risk of renal events in patients with type 2 diabetes

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours

Cardiorenal Syndrome : Mechanisms, Risk and Treatment

Cardiovascular protection for all individuals at high risk: evidence-based best practice

Aggiorn@rsi in Rete